NCT00615576View on ClinicalTrials.gov

Repeat Dose Study in Male Healthy Volunteer Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 26, 2008

Primary Completion Date

July 24, 2008

Study Completion Date

July 24, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

SB-656933

SB-656933 will be available as white film coated, round tablet and will be available in strengths of 50 milligrams, administered orally once daily.

DRUG

Placebo

A placebo tablet to visually match the SB-656933 tablet will also be supplied, administered orally once daily.

Trial Locations (1)

NW10 7NS

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY